Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 28
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06548932 | A Study to Evaluate the Safety, Tolerance, PK and PD Parameters of GZR33 and GZR101 in Healthy Male Adult Subjects | ||
| NCT03371108 | Gan & Lee Insulin Glargine Target Type (2) Evaluating Research | ||
| NCT04236895 | PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients | ||
| NCT06548815 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4 | ||
| NCT06737042 | Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants | ||
| NCT06199505 | A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM | ||
| NCT05328726 | Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects | ||
| NCT04254380 | Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro | ||
| NCT07146347 | Comparison Study of Insulin GZR4 With Insulin Degludec | ||
| NCT04235439 | PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males | ||
| NCT06670209 | A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects | ||
| NCT06556641 | A Clinical Study of GZR33 and GZR101 in Healthy Subjects | ||
| NCT06256549 | A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus | ||
| NCT06558708 | A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD | ||
| NCT06256523 | A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM) | ||
| NCT06256562 | A Study of GZR18 Injection in Obese/Overweight Patients | ||
| NCT04444427 | Evaluation of GLR2007 for Advanced Solid Tumors | ||
| NCT06554054 | A Study of GZR18 Tablet in Chinese Healthy Subjects | ||
| NCT06202079 | A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus | ||
| NCT06548997 | A Phase I Study of GZR18 Injection in Healthy Subjects | ||
| NCT06548906 | A Study of GZR4 Injection at Different Injection Sites | ||
| NCT03371082 | Gan & Lee Insulin Glargine Target Type (1) Evaluating Research | ||
| NCT06256536 | A Study of GZR18 Injection in Chinese Obese/Overweight Patients | ||
| NCT06548945 | A Phase I Study of GZR18 Injection in Obese/Overweight Subjects | ||
| NCT04237129 | PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males | ||
| NCT06547502 | Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment | ||
| NCT02506647 | PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes | ||
| NCT06553248 | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes |
